[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100524979":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":10,"locations":24,"responsibleParty":45,"collaborators":10,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Participants complete surveys, watch an educational video on HPV vaccination and undergo collection of blood and saliva samples on study. Patients also undergo cervical screening per standard of care and may receive a referral to gynecology if not up to date on anogenital screening.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":22,"role":23},"Kathryn M. Van Abel, M.D.","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[25],{"facility":22,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-92.4699,44.02163,{"lat":36,"lon":35},[39,44],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",{"name":21,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100524979","prospective-assessment-of-hpv-associated-anogenital-pathology-in-female-patients-and-female-partners-of-patients-with-confirmed-hpv-associated-oropharyngeal-carcinoma-pap-op-study-100524979",false,"NCT06115772","Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study","Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)","Inclusion Criteria:\n\n* \\* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester\n\n  * Age ≥ 18\n  * Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC\n  * Patient has given permission to give his\u002Fher blood\u002Fsaliva sample for research testing\n  * Ability to complete questionnaire(s) by themselves or with assistance\n\nExclusion Criteria:\n\n* \\* HPV(-) OPSCC\n\n  * Unable to provide informed consent\n  * Unwilling to attend screening visit at Mayo Clinic site, if indicated\n  * Unwilling\u002Funable to complete surveys electronically",true,"FEMALE","18 Years",{"count":58,"type":59},154,"ESTIMATED","OBSERVATIONAL","This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).",[63],"Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma","2026-02-19",{"date":66,"type":67},"2026-02-23","ACTUAL",{"date":69,"type":67},"2022-11-01",{"date":71,"type":59},"2027-11-01",{"name":5,"class":6},1]